AI and Bio-pharm are among the fast-developing industries. While trying to keep up with the speed of advancement has been challenging for many IP practitioners, we have no choice but to prepare for what is coming and stay ahead. This webinar will address strategies in protecting AI inventions for companies integrating AI into their business and important issues surrounding the Bio-pharm industry.
Topics to be discussed include:
- How to protect AI inventions and what issues you need to be aware of: patentability, claim drafting strategies, etc.
- Major case law updates in the Bio-pharm field, including patent eligibility in the diagnostic space (Illumina, Inc. v. Ariosa Diagnostics, Inc.) and the effect of “skinny” labeling practice on induced infringement (GlaxoSmithKline LLC v. Teva Pharms. USA, Inc.)
This webinar will be held in Japanese only.
Speakers:
Chiaki Kobayashi
Naoki Yoshida
